{{topic}}

Episode {{podcast.podcastEpisode}}:
{{podcast.podcastTitle}}

{{podcast.podcastDuration}} MIN
{{podcast.description}}
Host

Dr. Inés Dawson

Science communicator and Oxford graduate (DPhil Biomechanics of Insect Flight)

Inés is a science communicator and Oxford graduate (DPhil Biomechanics of Insect Flight). She runs the award-winning bilingual YouTube channel Draw Curiosity, and makes science stories interesting and accessible for a wide range of audiences. An enthusiastic and entertaining educational speaker, Inés uses creativity to make complex subjects simple and fun.

Guest

Dr. Michael Schmitt

Profile Byline

Michael studied at Veterinary Schools in Budapest, Hungary and Giessen, Germany. He obtained his Ph.D. in pharmacology and toxicology at the Veterinary University of Hannover, Germany. Since 2001, he has worked as a toxicologist and safety pharmacologist at Merck. Michael is our current Global Head of Chemical & Preclinical Safety. He and his team are responsible for all preclinical safety studies in animals, including the translation of adverse effects in animals to the human situation.

Guest

Philip Hewitt

Profile Byline

With great passion, Philip tries to better understand the mechanisms behind toxicity and to optimize the early detection of risks for humans. He joined Merck in 1998 and spent 20 years establishing and leading a Molecular Toxicology group in the Non-Clinical Safety (NCS) department. His work led to the opening of new laboratories, the hiring of specialist staff, and the introduction of tissue culture and molecular biology techniques. Philip currently leads the Early Investigative Toxicology practice.

Guest

Prof. Christopher Goldring

Profile Byline

Christopher is a Professor of Molecular and Cellular Pharmacology at the MRC Centre for Drug Safety Science (CDSS) with the University of Liverpool. His expertise lies in the fields of molecular toxicology, hepatology, in vitro models, application of stem cells in safety assessment, and the safety of regenerative medicine therapies. Christopher is member of the British Toxicology Society and the British Pharmacology Society.